XVIVO.ST
XVIVO.ST
SE0004840718
Xvivo Perfusion AB
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 812.165.000 822.415.000
1.2%
Cost of Revenue 212.673.000 206.000.000
3.2%
Gross Profit 599.492.000 616.415.000
2.7%
507.370.000 527.009.000
3.7%
Operating Income 92.122.000 89.406.000
3.0%
Pretax Income 38.561.000 199.948.000
80.7%
Net Income Common Stockholders 25.163.000 172.182.000
85.4%
-- --
--
-- --
--
ende